VRUSHALI S DABAK

Allopathic & Osteopathic Physicians|Internal Medicine DETROIT, MI NPI 1497963474

General Payments — all program years on this page

$4,703.01

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,371.83 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $525.001
Food and Beverage $429.946
Long term medical supply or device loan $398.804
Education $18.091

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $634.602
NOVARTIS PHARMACEUTICALS CORPORATION $398.804
Tempus AI, Inc $154.552
Daiichi Sankyo Inc. $144.202
ABBVIE INC. $21.591
Merck Sharp & Dohme Corporation $18.091

By program year

Program yearAmountRecords
2019 $145.672
2020 $90.411
2021 $2,541.922
2022 $110.851
2023 $442.334
2024 $1,371.8312

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086784759 Novartis Pharmaceuticals Corporation $99.70 08/23/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086784761 Novartis Pharmaceuticals Corporation $99.70 09/27/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086784763 Novartis Pharmaceuticals Corporation $99.70 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1086784765 Novartis Pharmaceuticals Corporation $99.70 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1089412496 Daiichi Sankyo Inc. $44.44 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089412498 Daiichi Sankyo Inc. $99.76 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103526569 ABBVIE INC. $21.59 01/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104546834 AstraZeneca Pharmaceuticals LP $525.00 12/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104740375 AstraZeneca Pharmaceuticals LP $109.60 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141780681 Merck Sharp & Dohme LLC $18.09 11/08/2024 Education Undisputed 01/23/2026 View at CMS
1150163222 Tempus AI, Inc $79.60 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150163224 Tempus AI, Inc $74.95 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.